Table 1 Comparison of CDH3 expression levels in primary tumors from patients with metastatic and nonmetastatic disease in the HCMDB
From: Synergistic potential of CDH3 in targeting CRC metastasis and enhancing immunotherapy
Exp ID | Cancer type | Primary site | Metastasis site | Design | Sample | Log2FC | P value |
|---|---|---|---|---|---|---|---|
EXP00124 | Colon cancer | colorectum | adrenal gland, liver, lung, lymph node | [primary tumors comparison] of different cancer types with metastasis | 18 | 2.682 | 1.625◊10− 4 |
EXP00125 | Colon cancer | colorectum | adrenal gland, liver, lung, lymph node | [metastasis tumors comparison] of different cancer types with metastasis | 26 | 2.809 | 8.584◊10− 4 |